"The thing that the space needs is a company making $100 million a year of revenue," Science Corp. CEO Max Hodak said.

Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.

Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related…